Laurel Wealth Advisors (California)’s PAVmed Inc. Series Z Warrant PAVMZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-45,000
Closed -$17K 438
2019
Q1
$17K Hold
45,000
﹤0.01% 403
2018
Q4
$14K Hold
45,000
﹤0.01% 352
2018
Q3
$21K Hold
45,000
0.01% 414
2018
Q2
$15K Buy
+45,000
New +$22.2K ﹤0.01% 381

Other funds holding PAVMZ

Laurel Wealth Advisors (California)'s PAVMZ Position: Q2 2019 in Review

Laurel Wealth Advisors (California) sold out of PAVmed Inc. Series Z Warrant (PAVMZ) in Q2 2019, closing a stake of 45,000 shares — an estimated $17K sold.

Laurel Wealth Advisors (California) first reported a position in PAVMZ in Q2 2018 and held it in 4 quarters. The position peaked at $21K in Q3 2018. 6 funds tracked by Wall St. Rank hold PAVMZ as of Q2 2019.

  • Laurel Wealth Advisors (California) reported no remaining PAVmed Inc. Series Z Warrant position as of Q2 2019 after selling out during the quarter.
  • Laurel Wealth Advisors (California) sold 45,000 PAVmed Inc. Series Z Warrant shares in Q2 2019, an estimated $17K.
  • Laurel Wealth Advisors (California) first reported a position in PAVmed Inc. Series Z Warrant in Q2 2018 and held it in 4 quarters.
  • Laurel Wealth Advisors (California)'s PAVmed Inc. Series Z Warrant position peaked at $21K in Q3 2018.
  • 6 funds tracked by Wall St. Rank held PAVmed Inc. Series Z Warrant as of Q2 2019.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q2 2019, filed 13 Aug 2019.